Travere Therapeutics, Inc. Quarterly Return On Assets in % from Q3 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Travere Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q3 2012 to Q3 2024.
  • Travere Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was -56.1 %, a 391% decline year-over-year.
  • Travere Therapeutics, Inc. annual Return On Assets for 2023 was -14.1 %, a 62% increase from 2022.
  • Travere Therapeutics, Inc. annual Return On Assets for 2022 was -37.1 %, a 57.5% decline from 2021.
  • Travere Therapeutics, Inc. annual Return On Assets for 2021 was -23.5 %, a 11.4% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -56.1 -44.6 -391% Jul 1, 2024 Sep 30, 2024
Q2 2024 -20.6 +21.2 +50.7% Apr 1, 2024 Jun 30, 2024
Q1 2024 -21.3 +17.4 +44.9% Jan 1, 2024 Mar 31, 2024
Q4 2023 -14.1 +23 +62% Oct 1, 2023 Dec 31, 2023
Q3 2023 -11.4 +22.6 +66.4% Jul 1, 2023 Sep 30, 2023
Q2 2023 -41.8 -12.6 -43.3% Apr 1, 2023 Jun 30, 2023
Q1 2023 -38.7 -12.8 -49.6% Jan 1, 2023 Mar 31, 2023
Q4 2022 -37.1 -13.5 -57.5% Oct 1, 2022 Dec 31, 2022
Q3 2022 -34 +0.61 +1.76% Jul 1, 2022 Sep 30, 2022
Q2 2022 -29.1 +4.59 +13.6% Apr 1, 2022 Jun 30, 2022
Q1 2022 -25.9 +6.82 +20.9% Jan 1, 2022 Mar 31, 2022
Q4 2021 -23.5 +3.04 +11.4% Oct 1, 2021 Dec 31, 2021
Q3 2021 -34.6 -22.3 -182% Jul 1, 2021 Sep 30, 2021
Q2 2021 -33.7 -18.8 -126% Apr 1, 2021 Jun 30, 2021
Q1 2021 -32.7 -15.5 -90.5% Jan 1, 2021 Mar 31, 2021
Q4 2020 -26.6 -3.45 -14.9% Oct 1, 2020 Dec 31, 2020
Q3 2020 -12.3 +6.49 +34.6% Jul 1, 2020 Sep 30, 2020
Q2 2020 -14.9 +5.78 +28% Apr 1, 2020 Jun 30, 2020
Q1 2020 -17.2 +2.23 +11.5% Jan 1, 2020 Mar 31, 2020
Q4 2019 -23.1 -6.12 -36% Oct 1, 2019 Dec 31, 2019
Q3 2019 -18.7 +1.51 +7.46% Jul 1, 2019 Sep 30, 2019
Q2 2019 -20.7 -5.7 -38.1% Apr 1, 2019 Jun 30, 2019
Q1 2019 -19.4 -6.31 -48.2% Jan 1, 2019 Mar 31, 2019
Q4 2018 -17 -5.38 -46.4% Oct 1, 2018 Dec 31, 2018
Q3 2018 -20.3 -10.4 -106% Jul 1, 2018 Sep 30, 2018
Q2 2018 -15 -1.48 -11% Apr 1, 2018 Jun 30, 2018
Q1 2018 -13.1 +0.28 +2.1% Jan 1, 2018 Mar 31, 2018
Q4 2017 -11.6 -2.48 -27.2% Oct 1, 2017 Dec 31, 2017
Q3 2017 -9.83 -1.82 -22.7% Jul 1, 2017 Sep 30, 2017
Q2 2017 -13.5 -33.1 -169% Apr 1, 2017 Jun 30, 2017
Q1 2017 -13.4 -31.5 -174% Jan 1, 2017 Mar 31, 2017
Q4 2016 -9.13 -34.3 -136% Oct 1, 2016 Dec 31, 2016
Q3 2016 -8.01 -32.4 -133% Jul 1, 2016 Sep 30, 2016
Q2 2016 19.6 +31.3 Apr 1, 2016 Jun 30, 2016
Q1 2016 18.2 +16.1 +770% Jan 1, 2016 Mar 31, 2016
Q4 2015 25.1 +109 Oct 1, 2015 Dec 31, 2015
Q3 2015 24.4 +115 Jul 1, 2015 Sep 30, 2015
Q2 2015 -11.7 +110 +90.4% Apr 1, 2015 Jun 30, 2015
Q1 2015 2.09 +307 Jan 1, 2015 Mar 31, 2015
Q4 2014 -83.6 +196 +70.1% Oct 1, 2014 Dec 31, 2014
Q3 2014 -91.1 +187 +67.2% Jul 1, 2014 Sep 30, 2014
Q2 2014 -122 +608 +83.3% Apr 1, 2014 Jun 30, 2014
Q1 2014 -304 +681 +69.1% Jan 1, 2014 Mar 31, 2014
Q4 2013 -280 +2.52K Oct 2, 2013 Dec 31, 2013
Q3 2013 -278 +215K +99.9% Jul 1, 2013 Sep 30, 2013
Q2 2013 -730 Apr 1, 2013 Jun 30, 2013
Q1 2013 -986 Jan 1, 2013 Mar 31, 2013
Q4 2012 -2.8K* Sep 1, 2012 Nov 30, 2012
Q3 2012 -215K Jul 1, 2012 Sep 30, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.